2021 Q4 Form 10-K Financial Statement

#000147793223006679 Filed on September 07, 2023

View on sec.gov

Income Statement

Concept 2021 Q4 2021 2020 Q4
Revenue $6.938K
YoY Change -73.47%
Cost Of Revenue $68.04K
YoY Change -77.85%
Gross Profit -$61.10K
YoY Change -78.25%
Gross Profit Margin -880.66%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development $0.00
YoY Change
% of Gross Profit
Depreciation & Amortization $0.00
YoY Change
% of Gross Profit
Operating Expenses $797.7K
YoY Change -8.73%
Operating Profit -$858.8K
YoY Change -25.64%
Interest Expense $96.03K
YoY Change -21.29%
% of Operating Profit
Other Income/Expense, Net -$10.16K
YoY Change -92.3%
Pretax Income
YoY Change
Income Tax
% Of Pretax Income
Net Earnings -$868.9K
YoY Change -32.48%
Net Earnings / Revenue -12524.17%
Basic Earnings Per Share
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2021 Q4 2021 2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $1.801K $252.00
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory $8.419K $10.13K
Prepaid Expenses $0.00 $0.00
Receivables $0.00
Other Receivables
Total Short-Term Assets $10.22K $10.38K
YoY Change -1.54%
LONG-TERM ASSETS
Property, Plant & Equipment $0.00 $49.49K
YoY Change -100.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $10.22K $10.38K
Total Long-Term Assets $0.00 $0.00
Total Assets $10.22K $10.38K
YoY Change -1.54%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $787.2K $609.5K
YoY Change 29.15%
Accrued Expenses $199.5K $107.0K
YoY Change 86.44%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.903M $1.437M
YoY Change 32.44%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $95.49K $201.4K
YoY Change -52.58%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.903M $1.437M
Total Long-Term Liabilities $95.49K $201.4K
Total Liabilities $1.999M $1.639M
YoY Change 22.0%
SHAREHOLDERS EQUITY
Retained Earnings -$4.590M -$3.721M
YoY Change 23.35%
Common Stock $15.90K $8.472K
YoY Change 87.63%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.989M -$1.628M
YoY Change
Total Liabilities & Shareholders Equity $10.22K $10.38K
YoY Change -1.54%

Cashflow Statement

Concept 2021 Q4 2021 2020 Q4
OPERATING ACTIVITIES
Net Income -$868.9K
YoY Change -32.48%
Depreciation, Depletion And Amortization $0.00
YoY Change
Cash From Operating Activities -$343.3K
YoY Change -24.89%
INVESTING ACTIVITIES
Capital Expenditures $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $319.8K
YoY Change 259.33%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $344.8K
YoY Change -21.7%
NET CHANGE
Cash From Operating Activities -$343.3K
Cash From Investing Activities $0.00
Cash From Financing Activities $344.8K
Net Change In Cash $1.549K
YoY Change -109.31%
FREE CASH FLOW
Cash From Operating Activities -$343.3K
Capital Expenditures $0.00
Free Cash Flow -$343.3K
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q4 us-gaap Assets
Assets
10380 usd
CY2021 dei Entity Central Index Key
EntityCentralIndexKey
0001753681
CY2021 dei Amendment Flag
AmendmentFlag
false
CY2021 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2021 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q3 dei Entity Public Float
EntityPublicFloat
0 usd
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
10000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
10000000 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
84738300 shares
CY2021Q4 us-gaap Share Price
SharePrice
0.05
CY2019 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
186023 usd
CY2021 elite Shares Issued For Subscriptions Shares
SharesIssuedForSubscriptionsShares
417600 shares
CY2019Q2 us-gaap Shortterm Debt Average Outstanding Amount
ShorttermDebtAverageOutstandingAmount
152500 usd
CY2021 dei Document Type
DocumentType
10-K
CY2021 dei Document Annual Report
DocumentAnnualReport
true
CY2021 dei Document Period End Date
DocumentPeriodEndDate
2021-12-31
CY2021 dei Document Transition Report
DocumentTransitionReport
false
CY2021 dei Entity File Number
EntityFileNumber
000-55987
CY2021 dei Entity Registrant Name
EntityRegistrantName
ELITE PERFORMANCE HOLDING CORP.
CY2021 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2021 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
82-5034226
CY2021 dei Entity Address Address Line1
EntityAddressAddressLine1
3301 NE 1st Ave Suite M704
CY2021 dei Entity Address City Or Town
EntityAddressCityOrTown
Miami
CY2021 dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
CY2021 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
33137
CY2021 dei City Area Code
CityAreaCode
844
CY2021 dei Local Phone Number
LocalPhoneNumber
426-2958
CY2021 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2021 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2021 dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
CY2021 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
No
CY2021 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2021 dei Entity Small Business
EntitySmallBusiness
true
CY2021 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2021 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2021 dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
130001300 shares
CY2021 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
20000 usd
CY2021 dei Auditor Name
AuditorName
M&K CPAS, PLLC
CY2021 dei Auditor Firm
AuditorFirmId
2738
CY2021 dei Auditor Location
AuditorLocation
Houston, TX
CY2021Q4 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
0 usd
CY2020Q4 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
0 usd
CY2021Q4 us-gaap Assets
Assets
10220 usd
CY2021Q4 elite Related Party Transaction Accounts Payable And Accrued Expenses
RelatedPartyTransactionAccountsPayableAndAccruedExpenses
373849 usd
CY2020Q4 elite Related Party Transaction Accounts Payable And Accrued Expenses
RelatedPartyTransactionAccountsPayableAndAccruedExpenses
222738 usd
CY2021Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
543004 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1903463 usd
CY2021Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
95485 usd
CY2021Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
95485 usd
CY2021Q4 us-gaap Liabilities
Liabilities
1998948 usd
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
35000000 shares
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
10000000 shares
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
1000 usd
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
465000000 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
98971300 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
84738300 shares
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
9896 usd
CY2021Q4 elite Common Stock Share Subscribed Issued
CommonStockShareSubscribedIssued
5000 usd
CY2020Q4 elite Common Stock Share Subscribed Issued
CommonStockShareSubscribedIssued
13803 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2585308 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-4589932 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-1988728 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
10220 usd
CY2021 us-gaap Revenues
Revenues
6938 usd
CY2020 us-gaap Revenues
Revenues
26154 usd
CY2021 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
68038 usd
CY2020 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
307132 usd
CY2021 us-gaap Gross Profit
GrossProfit
-61100 usd
CY2020 us-gaap Gross Profit
GrossProfit
-280978 usd
CY2021 us-gaap Legal Fees
LegalFees
125671 usd
CY2020 us-gaap Legal Fees
LegalFees
63228 usd
CY2021 us-gaap Advertising Expense
AdvertisingExpense
57124 usd
CY2020Q3 elite Stock Issued For Patent Rights
StockIssuedForPatentRights
200000 shares
CY2018Q1 us-gaap Shares Issued
SharesIssued
100000000 shares
CY2021Q4 us-gaap Equity Method Investment Ownership Percentage
EquityMethodInvestmentOwnershipPercentage
1 pure
CY2020 us-gaap Advertising Expense
AdvertisingExpense
258292 usd
CY2021 elite Consulting Expense
ConsultingExpense
321965 usd
CY2020 elite Consulting Expense
ConsultingExpense
339508 usd
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
292905 usd
CY2020 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
212896 usd
CY2021 us-gaap Operating Expenses
OperatingExpenses
797665 usd
CY2020 us-gaap Operating Expenses
OperatingExpenses
873924 usd
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-858765 usd
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-1154902 usd
CY2021 us-gaap Debt Instrument Decrease Forgiveness
DebtInstrumentDecreaseForgiveness
105867 usd
CY2020 us-gaap Debt Instrument Decrease Forgiveness
DebtInstrumentDecreaseForgiveness
0 usd
CY2021 us-gaap Asset Impairment Charges
AssetImpairmentCharges
20000 usd
CY2020 us-gaap Asset Impairment Charges
AssetImpairmentCharges
10000 usd
CY2021 us-gaap Interest Expense
InterestExpense
96029 usd
CY2020 us-gaap Interest Expense
InterestExpense
122005 usd
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-10162 usd
CY2020 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-132005 usd
CY2021 us-gaap Profit Loss
ProfitLoss
-868927 usd
CY2020 us-gaap Profit Loss
ProfitLoss
-1286907 usd
CY2021 elite Basic And Diluted Earnings Per Share
BasicAndDilutedEarningsPerShare
-0.01
CY2020 elite Basic And Diluted Earnings Per Share
BasicAndDilutedEarningsPerShare
-0.02
CY2021 elite Basic And Diluted Weighted Average Number Of Share Outstanding
BasicAndDilutedWeightedAverageNumberOfShareOutstanding
95357059 shares
CY2020 elite Basic And Diluted Weighted Average Number Of Share Outstanding
BasicAndDilutedWeightedAverageNumberOfShareOutstanding
67891464 shares
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-928567 usd
CY2020 elite Subscription Shares Issued For Cash Amount
SubscriptionSharesIssuedForCashAmount
0 usd
CY2020 elite Shares Issued For Finance Fees Amount
SharesIssuedForFinanceFeesAmount
20000 usd
CY2020 elite Shares To Be Issued For Services
SharesToBeIssuedForServices
30781 usd
CY2020 elite Subscriptions Received
SubscriptionsReceived
89000 usd
CY2020 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
8000 usd
CY2020 elite Related Party Debt Forgiveness
RelatedPartyDebtForgiveness
439545 usd
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-1286907 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-1628148 usd
CY2021 elite Shares Issued For Subscriptions Amount
SharesIssuedForSubscriptionsAmount
208800 usd
CY2021 elite Shares Issued For License From To Be Issued Amount
SharesIssuedForLicenseFromToBeIssuedAmount
0 usd
CY2021 elite Shares Issued For Patents Amount
SharesIssuedForPatentsAmount
20000 usd
CY2021 elite Shares Issued For Licensing Agreement Amount
SharesIssuedForLicensingAgreementAmount
0 usd
CY2021 elite Shares Issued For Commitment Fee Amount
SharesIssuedForCommitmentFeeAmount
3000 usd
CY2021 elite Reg D Subscriptions Amount
RegDSubscriptionsAmount
111000 usd
CY2021 elite Shares To Be Issued For Liability Settlement
SharesToBeIssuedForLiabilitySettlement
5000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-868927 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-1988728 usd
CY2021 us-gaap Profit Loss
ProfitLoss
-868927 usd
CY2020 us-gaap Profit Loss
ProfitLoss
-1286907 usd
CY2021 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
3053 usd
CY2020 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
58921 usd
CY2021 elite Shares Issued For Services
SharesIssuedForServices
160547 usd
CY2020 elite Shares Issued For Services
SharesIssuedForServices
28781 usd
CY2021 elite Gain On Forgiveness Of Ppp Loan
GainOnForgivenessOfPppLoan
-105867 usd
CY2020 elite Gain On Forgiveness Of Ppp Loan
GainOnForgivenessOfPppLoan
0 usd
CY2021 elite Goodwill Impairment Loss Of Licensing Agreement
GoodwillImpairmentLossOfLicensingAgreement
20000 usd
CY2020 elite Goodwill Impairment Loss Of Licensing Agreement
GoodwillImpairmentLossOfLicensingAgreement
10000 usd
CY2021 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1709 usd
CY2020 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-142202 usd
CY2021 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
0 usd
CY2020 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-2638 usd
CY2021 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
151111 usd
CY2020 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
145781 usd
CY2021 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
295123 usd
CY2020 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
441600 usd
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-343251 usd
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-456984 usd
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
CY2021 us-gaap Proceeds From Loan Originations1
ProceedsFromLoanOriginations1
0 usd
CY2020 us-gaap Proceeds From Loan Originations1
ProceedsFromLoanOriginations1
201352 usd
CY2021 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
25000 usd
CY2020 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 usd
CY2021 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
24000 usd
CY2020 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
150000 usd
CY2021 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
24000 usd
CY2020 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
0 usd
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
319800 usd
CY2020 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
89000 usd
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
344800 usd
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
440352 usd
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
1549 usd
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-16632 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
252 usd
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
16884 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1801 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
252 usd
CY2021 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2020 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2020 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2021 us-gaap Stock Issued1
StockIssued1
3000 usd
CY2020 us-gaap Stock Issued1
StockIssued1
20000 usd
CY2021 elite Shares To Be Issued For Accounts Payable Forgiveness
SharesToBeIssuedForAccountsPayableForgiveness
5000 usd
CY2020 elite Shares To Be Issued For Accounts Payable Forgiveness
SharesToBeIssuedForAccountsPayableForgiveness
0 usd
CY2021 elite Shares Issued For Stock Payable
SharesIssuedForStockPayable
13803 shares
CY2020 elite Shares Issued For Stock Payable
SharesIssuedForStockPayable
962770 shares
CY2021 elite Shares Issued For Patents
SharesIssuedForPatents
20000 usd
CY2021 elite Convertible Note Issued For Accounts Payable
ConvertibleNoteIssuedForAccountsPayable
20000 usd
CY2020 elite Convertible Note Issued For Accounts Payable
ConvertibleNoteIssuedForAccountsPayable
0 usd
CY2021 elite Forgiveness Of Rpt Debt Interest And Ap
ForgivenessOfRptDebtInterestAndAp
0 usd
CY2020 elite Forgiveness Of Rpt Debt Interest And Ap
ForgivenessOfRptDebtInterestAndAp
439545 usd
CY2021 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
500 usd
CY2020 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
10000 usd
CY2021 us-gaap Basis Of Accounting
BasisOfAccounting
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The consolidated financial statements include the accounts and operations of the Company, and its wholly owned subsidiary. All significant intercompany balances and transactions have been eliminated in preparing the consolidated financial statements. The Company has made certain reclassification adjustments to conform prior periods’ Consolidated Financial Statements and Notes to the Consolidated Financial Statements to the current presentation.</p>
CY2021Q4 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 usd
CY2021Q4 us-gaap Allowance For Doubtful Accounts Premiums And Other Receivables
AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables
0 usd
CY2020Q4 us-gaap Allowance For Doubtful Accounts Premiums And Other Receivables
AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables
0 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
8419 usd
CY2020Q4 us-gaap Inventory Net
InventoryNet
10128 usd
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
0 usd
CY2020Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
0 usd
CY2021Q4 us-gaap Convertible Debt
ConvertibleDebt
545250 usd
CY2021Q4 us-gaap Interest Payable Current
InterestPayableCurrent
158914 usd
CY2021Q4 elite Common Stock Convertible Shares Issuable
CommonStockConvertibleSharesIssuable
14083283 shares
CY2021 us-gaap Stock Issued During Period Shares Other
StockIssuedDuringPeriodSharesOther
100000 shares
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
0 usd
CY2020 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
0 usd
CY2021 us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The preparation of financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p>
CY2021 us-gaap Revenues
Revenues
6938 usd
CY2020 us-gaap Revenues
Revenues
26154 usd
CY2018Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2021Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
4589932 usd
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
963886 usd
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
963886 usd
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
963886 usd
CY2020Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
781411 usd
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
963886 usd
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
781411 usd
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
CY2020Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
CY2021 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
20000 usd
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
465000000 shares
CY2021 elite Description Of Shares Registered In The S1 Registration Statement
DescriptionOfSharesRegisteredInTheS1RegistrationStatement
the company has raised $1,250,200 (25,000,000 shares issued and 0 of shares to be issued) through a registered offering for $1,250,000 which was registered with the SEC through an S1 registration statement which went effective on April 23, 2019
CY2020Q1 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
100000 shares
CY2020Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
5000 usd
CY2020Q2 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
50000 shares
CY2020Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
2500 usd
CY2021 elite Impair License Fee
ImpairLicenseFee
10000 usd
CY2021 elite Shares Issued For Licensing Agreement Shares
SharesIssuedForLicensingAgreementShares
5000000 shares
CY2021 elite Share Issued For Licensing Agreement Amount
ShareIssuedForLicensingAgreementAmount
500 usd
CY2021 elite Shares Issued For Subscriptions Amount
SharesIssuedForSubscriptionsAmount
208800 usd
CY2021 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
3287000 shares
CY2021 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
160547 usd
CY2021 elite Shares Issued For Commitment Fee Shares
SharesIssuedForCommitmentFeeShares
60000 shares
CY2021 elite Shares Issued For Commitment Fee Amount
SharesIssuedForCommitmentFeeAmount
3000 usd
CY2021 us-gaap Stock Issued During Period Shares Acquisitions
StockIssuedDuringPeriodSharesAcquisitions
400000 shares
CY2021 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
20000 usd
CY2021 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
20000 usd
CY2021 elite Reg D Subscriptions Shares
RegDSubscriptionsShares
111000 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
98971300 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
35000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
10000000 shares
CY2021 elite Schedule Of Stock Issued Acquisition Tbleext Block
ScheduleOfStockIssuedAcquisitionTbleextBlock
<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%"><tbody><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Additional paid-in-capital</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">6,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Common stock, based on par value of $0.0001</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(5,000 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Preferred stock, based on par value of $0.0001</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(1,000 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr></tbody></table>
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
6000 usd
CY2021Q4 elite Common Stock Based On Par Value Of00001
CommonStockBasedOnParValueOf00001
-5000 usd
CY2021Q4 elite Preferred Stock Based On Par Value Of00001
PreferredStockBasedOnParValueOf00001
-1000 usd
CY2020Q2 us-gaap Shortterm Debt Average Outstanding Amount
ShorttermDebtAverageOutstandingAmount
201352 usd
CY2020Q2 elite Interest Rates
InterestRates
0.0098 pure
CY2020Q2 us-gaap Derivative Maturity Dates
DerivativeMaturityDates
2022-04-23
CY2021Q4 us-gaap Accounts And Notes Receivable Net
AccountsAndNotesReceivableNet
0 usd
CY2020Q4 us-gaap Accounts And Notes Receivable Net
AccountsAndNotesReceivableNet
0 usd
CY2020Q4 us-gaap Inventory Net
InventoryNet
10128 usd
CY2020Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
10128 usd
CY2020Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
0 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
8419 usd
CY2021Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
8419 usd
CY2021Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
0 usd

Files In Submission

Name View Source Status
elite-20211231_cal.xml Edgar Link unprocessable
0001477932-23-006679-index-headers.html Edgar Link pending
0001477932-23-006679-index.html Edgar Link pending
0001477932-23-006679.txt Edgar Link pending
0001477932-23-006679-xbrl.zip Edgar Link pending
elite-20211231.xsd Edgar Link pending
elite_10k.htm Edgar Link pending
elite_10kimg15.jpg Edgar Link pending
elite_10kimg33.jpg Edgar Link pending
elite_10kimg34.jpg Edgar Link pending
elite_ex311.htm Edgar Link pending
elite_ex312.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
elite-20211231_def.xml Edgar Link unprocessable
elite-20211231_lab.xml Edgar Link unprocessable
elite-20211231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
elite_10k_htm.xml Edgar Link completed
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending